These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 17578887

  • 1. Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation.
    Cheng H, Zhou L, Zhu W, Wang A, Tang C, Chan O, Sherwin RS, McCrimmon RJ.
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E705-12. PubMed ID: 17578887
    [Abstract] [Full Text] [Related]

  • 2. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation.
    McCrimmon RJ, Song Z, Cheng H, McNay EC, Weikart-Yeckel C, Fan X, Routh VH, Sherwin RS.
    J Clin Invest; 2006 Jun; 116(6):1723-30. PubMed ID: 16741581
    [Abstract] [Full Text] [Related]

  • 3. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation.
    McCrimmon RJ, Fan X, Cheng H, McNay E, Chan O, Shaw M, Ding Y, Zhu W, Sherwin RS.
    Diabetes; 2006 Jun; 55(6):1755-60. PubMed ID: 16731839
    [Abstract] [Full Text] [Related]

  • 4. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression.
    Lee S, Smith GW, Vale W, Lee KF, Rivier C.
    Alcohol Clin Exp Res; 2001 Mar; 25(3):427-33. PubMed ID: 11290855
    [Abstract] [Full Text] [Related]

  • 5. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia.
    McCrimmon RJ, Shaw M, Fan X, Cheng H, Ding Y, Vella MC, Zhou L, McNay EC, Sherwin RS.
    Diabetes; 2008 Feb; 57(2):444-50. PubMed ID: 17977955
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
    Muramatsu T, Inoue K, Iwasaki S, Yamauchi T, Hayashi T, Kiriike N.
    Pharmacol Biochem Behav; 2006 Oct; 85(2):435-40. PubMed ID: 17109941
    [Abstract] [Full Text] [Related]

  • 7. Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress.
    Huang Q, Timofeeva E, Richard D.
    J Endocrinol; 2006 Oct; 191(1):179-88. PubMed ID: 17065401
    [Abstract] [Full Text] [Related]

  • 8. ATP-sensitive K(+) channels regulate the release of GABA in the ventromedial hypothalamus during hypoglycemia.
    Chan O, Lawson M, Zhu W, Beverly JL, Sherwin RS.
    Diabetes; 2007 Apr; 56(4):1120-6. PubMed ID: 17251273
    [Abstract] [Full Text] [Related]

  • 9. Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors.
    O'Malley D, Dinan TG, Cryan JF.
    Peptides; 2010 Apr; 31(4):662-70. PubMed ID: 20096320
    [Abstract] [Full Text] [Related]

  • 10. Modulation of β-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia.
    Szepietowska B, Zhu W, Chan O, Horblitt A, Dziura J, Sherwin RS.
    Diabetes; 2011 Dec; 60(12):3154-8. PubMed ID: 22013013
    [Abstract] [Full Text] [Related]

  • 11. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C, Cordero MI, Ugolini A, Varea E, Caberlotto L, Large CH.
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [Abstract] [Full Text] [Related]

  • 12. Corticotropin-releasing factor and its receptors in the brain of rats with insulin and corticosterone deficits.
    Huang Q, Timofeeva E, Richard D.
    J Mol Endocrinol; 2006 Oct; 37(2):213-26. PubMed ID: 17032740
    [Abstract] [Full Text] [Related]

  • 13. The blockage of ventromedial hypothalamus CRF type 2 receptors impairs escape responses in the elevated T-maze.
    Silva MSCF, Souza TMO, Pereira BA, Ribeiro DA, Céspedes IC, Bittencourt JC, Viana MB.
    Behav Brain Res; 2017 Jun 30; 329():41-50. PubMed ID: 28435125
    [Abstract] [Full Text] [Related]

  • 14. Differential stress-induced alterations of colonic corticotropin-releasing factor receptors in the Wistar Kyoto rat.
    o'malley D, Julio-Pieper M, Gibney SM, Gosselin RD, Dinan TG, Cryan JF.
    Neurogastroenterol Motil; 2010 Mar 30; 22(3):301-11. PubMed ID: 19807869
    [Abstract] [Full Text] [Related]

  • 15. Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia.
    Chan O, Zhu W, Ding Y, McCrimmon RJ, Sherwin RS.
    Diabetes; 2006 Apr 30; 55(4):1080-7. PubMed ID: 16567532
    [Abstract] [Full Text] [Related]

  • 16. CRF receptor type 1 mediates continual hypoxia-induced CRF peptide and CRF mRNA expression increase in hypothalamic PVN of rats.
    Xu JF, Chen XQ, Du JZ, Wang TY.
    Peptides; 2005 Apr 30; 26(4):639-46. PubMed ID: 15752579
    [Abstract] [Full Text] [Related]

  • 17. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia.
    Levin BE, Becker TC, Eiki J, Zhang BB, Dunn-Meynell AA.
    Diabetes; 2008 May 30; 57(5):1371-9. PubMed ID: 18292346
    [Abstract] [Full Text] [Related]

  • 18. EphA5-EphrinA5 interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local glutamine/glutamate balance during hypoglycemia.
    Szepietowska B, Zhu W, Czyzyk J, Eid T, Sherwin RS.
    Diabetes; 2013 Apr 30; 62(4):1282-8. PubMed ID: 23274893
    [Abstract] [Full Text] [Related]

  • 19. I.c.v. administration of the nonsteroidal glucocorticoid receptor antagonist, CP-472555, prevents exacerbated hypoglycemia during repeated insulin administration.
    Kale AY, Paranjape SA, Briski KP.
    Neuroscience; 2006 Jun 30; 140(2):555-65. PubMed ID: 16626867
    [Abstract] [Full Text] [Related]

  • 20. Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation.
    Fioramonti X, Marsollier N, Song Z, Fakira KA, Patel RM, Brown S, Duparc T, Pica-Mendez A, Sanders NM, Knauf C, Valet P, McCrimmon RJ, Beuve A, Magnan C, Routh VH.
    Diabetes; 2010 Feb 30; 59(2):519-28. PubMed ID: 19934009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.